MDP Logo

Eliza Low

Partner

LLB(Hons) BA(Hons)
Contact

+61 3 9620 9660
[email protected]

LinkedIn

Vcard

I am an experienced corporate and commercial lawyer who helps multinational corporations, entrepreneurial businesses and successful family-owned companies realise their investments, navigate legal risks and set themselves up for success.

For more than ten years, I have advised clients on a range of corporate and commercial matters and negotiated M&A deals worth $200k to $4b in the industrial, engineering, financial services, technology, FMCG, healthcare, manufacturing and professional services sectors.

I honed my skills at Baker McKenzie, one of the largest international law firms, and spent nine years working on multi-jurisdictional deals and corporate restructures in both the Melbourne and London offices.

In addition to my corporate practice, I advise clients on outbound and inbound foreign market entry strategies as well as a broad range of commercial matters including shareholders agreements, customer agreements, joint venture agreements, licensing and distribution agreements and research and collaboration agreements.

I was previously the company secretary of a multinational fuel analytics technology company, Leighton O’Brien, and director of not-for-profit social violence prevention organisation Step Back Think.  I am currently the company secretary of the not-for-profit kindergarten, Little St Margarets.

Education

Areas of Practice

  • Corporate and M&A
  • Commercial

Recent Matters

  • Advising one of founding shareholders on sale of shares in Cyclotek, the leading private producer of radioisotopes in Australia and New Zealand, to private equity firm Five V Capital.
  • Advising on sale of CE McDonald Insurance Brokers to Austbrokers Comsure.
  • Advising leading national cybersecurity technology provider on negotiating master services agreements, supplier agreements and customer agreements.
  • Advising Leighton O’Brien on sale of group to Charlesbank Capital-backed Titan Cloud.
  • Advising local biotechnology company on research and collaboration agreements and licence agreements.
Scroll to Top